🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This unblinded pilot study is intended to assess the feasibility of a large...
Status
Completed
Location
Mount Sinai Hospital
Start Date
2008-11
Trial ID
NCT00784784
The study is a single centre, phase I, double-blind, randomized, placebo-co...
Status
Completed
Location
Kazakh National Medical University
Start Date
2016-05
Trial ID
NCT03028116
Treatments Being Tested
The primary purpose of this study is to demonstrate the efficacy of an inve...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT00566345
The purpose of this study is to evaluate the safety and immunogenicity of G...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-04-29
Trial ID
NCT02369341
Treatments Being Tested
This is a phase I, double-blind, randomized, placebo-controlled trial with ...
Status
Completed
Location
Clinical Center of Serbia
Start Date
2015-11
Trial ID
NCT02585700
Treatments Being Tested
This is a randomized, single-blinded, Phase IV, monocentric study in health...
Status
Unknown
Location
National Health Centre
Start Date
2008-11
Trial ID
NCT01119157
Treatments Being Tested
The study is a single centre, phase II, double-blind, randomized, comparati...
Status
Completed
Location
Kazakh National Medical University
Start Date
2016-10
Trial ID
NCT03016143
Treatments Being Tested
An open label, non-comparative bridging study to evaluate the safety of GCF...
Status
Completed
Location
Ben Luc Health centre
Start Date
2015-11
Trial ID
NCT02723812
Treatments Being Tested
This is a Phase 1, randomized, controlled, dose-ranging clinical trial to a...
Status
Not Yet Recruiting
Location
University of Maryland, School of Medicine, Center for Vaccine Development and Global Health
Start Date
2026-08-07
Trial ID
NCT07703514
This was an extensive, double-blind, randomized, placebo-controlled phase 3...
Status
Completed
Location
CDC Ha Nam
Start Date
2020-09-05
Trial ID
NCT04695717
Treatments Being Tested